SCHEMBL4583413

SCHEMBL4583413

COc1ccc(C[C@@H](CN2C(=O)c3ccccc3C2=O)NC(=O)OCC(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
CASP3 P42574 1/20 0.47
GAA P10253 1/20 0.47
ALDH1A1 P00352 4/20 0.45
HSD17B10 Q99714 2/20 0.45
POLB P06746 1/20 0.45
APEX1 P27695 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
NPC1 O15118 1/20 0.45
RPS6KA2 Q15349 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MEN1 O00255 1/20 0.42
MMP1 P03956 2/20 0.42
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8233202 0.84 ATM (0.49) KMT2ACASP3GAAALDH1A1HSD17B10
SCHEMBL4336440 0.82 CYP2D6 (0.41) KMT2AGAAALDH1A1TDP1CYP1A2
SCHEMBL4374776 0.82 CYP3A4 (0.48) KMT2AGAAALDH1A1POLBTDP1
SCHEMBL4379672 0.80 KMT2A (0.43) KMT2AALDH1A1POLBCYP1A2CYP3A4
SCHEMBL4583744 0.80 CACNA1B (0.47) ALDH1A1CYP3A4MMP1ATM
SCHEMBL4381682 0.78 KMT2A (0.43) KMT2AALDH1A1POLBCYP3A4CYP2D6
SCHEMBL13919634 0.77 CTSL (0.51) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL5551458 0.76 PLA2G1B (0.47) KMT2AGAAALDH1A1HSD17B10CYP3A4
SCHEMBL13919601 0.76 ATM (0.49) ATM
SCHEMBL4900744 0.73 ATM (0.60) CYP3A4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968568-A2 INHIBITORS OF Akt ACTIVITY SmithKline Beecham Corporation (US) 2008-09-17 EP disclosed
WO-2007076423-A2 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2007-07-05 WO disclosed